Analyst Ratings for Tonix Pharma (TNXP)
TNXP Rating Summary
TNXP Price Target Summary
- Highest: $3.00 (Dawson James)
- Lowest: $1.50 (Noble Capital)
- Average: $2.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$2.25 (+1306.3%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 53%
Avg. $ Target:
$2.25 (+1306.3%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 53%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/28/2024 | Dawson James | Jason H. Kolbert | New Coverage | Buy (N/A) |
3.00 (N/A) |
0.37 (0.16) |
-56.76% | Details |
| 4/18/2022 | Noble Capital » Updated 4/11/2024 |
Robert LeBoyer | New Coverage | Outperform (N/A) |
1.50 (10.00) |
0.19 (0.16) |
-15.79% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
